Sergeev AY, Gupta AK, Sergeev YV. The Scoring Clinical Index for Onychomycosis (SCIO index). Skin Therapy Lett. 2002; 7 Suppl 1: 6-7.
Lecha M, Effendy I, Feuilhade de Chauvin M et al. Treatment options - development of consensus guidelines. J Eur Acad Dermatol Venereol. 2005; 19 Suppl 1: 25-33.Go to original source...Go to PubMed...
Vlahovic TC, Joseph WS, Scher RK et al. Diagnosis and management of onychomycosis. J Am Podiatr Med Assoc. 2016; 106: 155-162.Go to original source...Go to PubMed...
Wollina U, Nenoff P, Haroske G, Haenssle HA. The diagnosis and treatment of nail disorders. Dtsch Arztebl Int. 2016; 113: 509-518.Go to original source...Go to PubMed...
Carney C, Tosti A, Daniel R et al. A new classification systém for grading the severity of onychomycosis: Onychomycosis Severity Index. Arch Dermatol. 2011; 147: 1277-1282.Go to original source...Go to PubMed...
Baran R, Kaoukhov A. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venereol. 2005; 19:21-29.Go to original source...Go to PubMed...
Westerberg DP, Voyack MJ. Onychomycosis: Current trends in diagnosis and treatment. Am Fam Physician. 2013; 88: 762-770.Go to PubMed...
Iorizzo M, Ilona H, Derveniece A, Mikazans I. Ciclopirox 8% HPCH nail lacquer in the treatment of mild-to-moderate onychomycosis: a randomized, double-blind amorolfine controlled study using a blinded evaluator. Skin Appendage Disord. 2015; 1: 134-140.Go to original source...Go to PubMed...
Gupta AK, Paquet M, Simpson, Tavakkol A. Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta-analysis of efficacy for continuous and intermittent regimens. J Eur Acad Dermatol Venereol. 2013; 27: 267-272.Go to original source...Go to PubMed...
Scher RK, Tosti A, Joseph WS et al. Onychomycosis diagnosis and management: perspectives from a joint dermatology-podiatry roundtable. J Drugs Dermatol. 2015; 14: 1016-1021.Go to PubMed...
Madam, Sir, please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert). Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.
I declare:
that I have met the above instruction
I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited